FDA 483 - Expack Usa Inc - October 18, 2023

Expack USA, Inc. was inspected and cited for significant deficiencies across its quality system, personnel training, and manufacturing controls. Observations included failures in supplier qualification, employee GMP training, equipment validation, cleaning validation, and temperature monitoring for drug product storage. These issues indicate a lack of adherence to good manufacturing practices that could impact drug product quality and purity.